<!DOCTYPE html>
<html>
<head>
    <title>BREAKING: Federal Register: Implantation or Injectable Dosage Form New Animal Drugs; Maropitant; Tildipirosin</title>
    <meta charset="UTF-8">
    <style>
        body { font-family: Georgia, serif; max-width: 800px; margin: 0 auto; padding: 20px; }
        h1 { border-bottom: 2px solid #333; }
        .breaking { background: #fff3cd; border-left: 4px solid #dc3545; padding: 15px; }
        .source { background: #f8f9fa; padding: 10px; margin-top: 20px; font-size: 0.9em; }
        .timestamp { color: #666; }
    </style>
</head>
<body>
    <h1>BREAKING: Federal Register: Implantation or Injectable Dosage Form New Animal Drugs; Maropitant; Tildipirosin</h1>
    <p class="timestamp">Published: 2012-07-03 | Source: Federal Register</p>
    <div class="breaking">
        <p><strong>The Food and Drug Administration (FDA) is amending the animal drug regulations to reflect approval actions for new animal drug applications (NADAs) and abbreviated new animal drug applications (ANADAs) during May 2012. FDA is also informing the public of the availability of summaries of the basis of approval and of environmental review documents, where applicable.</strong></p>
    </div>
    <h2>Document Details</h2>
    <p><strong>Document Type:</strong> Rule</p>
    <p><strong>Agency:</strong> Health and Human Services Department, Food and Drug Administration</p>
    <p><strong>Document Number:</strong> 2012-16203</p>
    <p><strong>Publication Date:</strong> 2012-07-03</p>
    <h2>Official Source</h2>
    <p>Read the full document at: <a href="https://www.federalregister.gov/documents/2012/07/03/2012-16203/implantation-or-injectable-dosage-form-new-animal-drugs-maropitant-tildipirosin">https://www.federalregister.gov/documents/2012/07/03/2012-16203/implantation-or-injectable-dosage-form-new-animal-drugs-maropitant-tildipirosin</a></p>
    <div class="source"><strong>Source:</strong> Federal Register - 2012-16203</div>
    <p><a href="index.html">Back to Breaking News Wire</a></p>
</body>
</html>
